Health Catalyst, Inc.
NasdaqGS:HCAT
$ 6.73
$0.00 (0.00%)
$ 6.73
$0.00 (0.00%)
End-of-day quote: 05/25/2024

Health Catalyst financials at a glance

The revenue of Health Catalyst is reported as 0.29594 billion Dollars in the fiscal year 2023. The earnings were 0.15 Dollars per share in 2023, which was 157.69 higher than 2022. And about -0.00624 billion Dollars are reported as free cash flow in the financials of Health Catalyst 2023. No dividends were paid to the shareholders of the Health Catalyst stock NasdaqGS:HCAT in the financial year 2023.

$295.94M
Revenue
$0.15
Earnings Per Share
45.56%
Gross Margin %
$-48.19M
Free Cash Flow
Revenue
295.94
Earnings Per Share
0.15
Gross Margin %
45.56
Free Cash Flow
-48.19

Financials

Year Year TTM 2023 2022 2021 2020 2019
Rev. Revenue N/A $295.94M $276.24M $241.93M $188.85M $154.94M
GM % Gross Margin % 46.44% 45.56% 49.07% 48.68% 48.06% 51.44%
OM Operating Margin -33.11% -29.38% -44.49% -47.09% -41.29% -35.12%
EPS Earnings Per Share $-2.23 $0.15 $-0.26 $-0.45 $-0.68 $-0.93
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0.00% -0.00% -0.00% -0.00% 0
Sha. Shares N/AM 58.56M 55.81M 53.35M 44.04M 37.26M
OCF Operating Cash Flow N/A $-5.00M $-35.27M $-23.12M $-26.15M $-32.18M
FCF Free Cash Flow N/A $-48.19M $-37.44M $-33.57M $-35.37M $-34.58M
FCFS Free Cash Flow Per Share $-0.80 $-0.84 $-0.98 $-0.88 $-0.93 $-1.95